Advanced Medical Solutions Group (LON:AMS) Stock Passes Above 200 Day Moving Average - What's Next?

Key Points

• Advanced Medical Solutions' shares crossed above their 200-day moving average
• Analyst sentiment is a Moderate Buy (three Buys, one Hold) with an average target of GBX 270.25; individual targets include GBX 300 (Berenberg) and GBX 260 (RBC).
• The stock sits on a market cap of £534.5m and carries a premium valuation (P/E of 54.65) alongside modest profitability (net margin 4.35%), indicating high expectations for future earnings.

Advanced Medical Solutions Group plc (LON:AMS - Get Free Report)'s stock price crossed above its two hundred day moving average during trading on Wednesday . The stock has a two hundred day moving average of GBX 215 and traded as high as GBX 247.50. Advanced Medical Solutions Group shares last traded at GBX 245.34, with a volume of 745,721 shares traded.

Analyst Ratings Changes

Several research analysts recently issued reports on AMS shares. Berenberg Bank reaffirmed a "buy" rating and set a GBX 300 target price on shares of Advanced Medical Solutions Group in a research report on Wednesday, March 18th. Royal Bank Of Canada reaffirmed a "sector perform" rating and set a GBX 260 target price on shares of Advanced Medical Solutions Group in a research report on Thursday, April 9th. Three research analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the company's stock. According to MarketBeat.com, the company currently has an average rating of "Moderate Buy" and an average target price of GBX 270.25.

Advanced Medical Solutions Group Stock Performance

The firm has a market capitalization of £534.52 million, a P/E ratio of 54.65, a price-to-earnings-growth ratio of 5.00 and a beta of 0.63. The company has a current ratio of 2.79, a quick ratio of 4.58 and a debt-to-equity ratio of 31.50. The company has a 50-day moving average of GBX 212.71 and a 200-day moving average of GBX 215.

Advanced Medical Solutions Group (LON:AMS - Get Free Report) last announced its earnings results on Wednesday, March 18th. The company reported GBX 11.98 earnings per share (EPS) for the quarter. Advanced Medical Solutions Group had a return on equity of 3.87% and a net margin of 4.35%. On average, equities analysts anticipate that Advanced Medical Solutions Group plc will post 9.8159509 earnings per share for the current fiscal year.

About Advanced Medical Solutions Group

AMS is a world-leading independent developer and manufacturer of innovative tissue-healing technology, focused on quality outcomes for patients and value for payers. AMS has a wide range of surgical products including tissue adhesives, sutures, haemostats, internal fixation devices and internal sealants, which it markets under its brands LiquiBand®, RESORBA®, LiquiBandFix8®, and Seal-G®. AMS also supplies wound care dressings such as silver alginates, alginates and foams through its ActivHeal® brand as well as under white label.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.